MedTrace Logo

ReAcT CO2: A Study to Assess TcCO2 to Guide Acute NIV

NCT05674760 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-01-06

No results posted yet for this study

Summary

Arterial blood sampling is needed to monitor carbon dioxide and PH but is often painful. The aim of this study is to determine whether continuous carbon dioxide monitoring with a skin probe reduces the need for arterial blood sampling by at least 30%. The investigators will also study the safety and effectiveness of skin probe monitoring to manage non-invasive ventilation (NIV).

Conditions

  • Acute Hypercapnic Respiratory Failure

Interventions

DEVICE

Trancutaneous CO2 monitoring (using TCM5 device)

Patients in the Transcutaneous arm will undergo Trancutaneous CO2 monitoring (using TCM5 device)

OTHER

Arterial Blood Gas (ABG) sampling

Arterial Blood Gas (ABG) sampling to monitor CO2 - as per standard practice.

Sponsors & Collaborators

  • Nottingham University Hospitals NHS Trust

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-10
Primary Completion
2024-02-07
Completion
2024-02-10

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05674760 on ClinicalTrials.gov